Category Archives: IP Rights

India-US trade talks: Trading lives?

Source: Deccan Herald 21st September 2019 Prime Minister Narendra Modi is set to meet US President Donald Trump to discuss trade issues between the two countries in a few days’ time. Health workers and doctors working with patients suffering from tuberculosis, … Continue reading

Posted in IP Rights, Trade Agreements, US-India FTA | Leave a comment

Pharma talks: Govt urged to safeguard public health

Source: Times Of India 21st September 2019   Mumbai: Ahead of PM Narendra Modi’s visit to the US to discuss a ‘trade-package’ with US President, health activists, patient groups and the domestic medical device industry have urged the government not to … Continue reading

Posted in FTA, IP Rights, Right to Health, Trade Agreements, US-India FTA | Leave a comment

Activists urge Modi to reject India-US trade deal as it may hit access to affordable healthcare

Source: Live Mint 21st September 2019 The letter to the prime minister comes ahead of his visit to the US starting Sunday, where he is scheduled to meet US President Donald Trump NEW DELHI : A civil society group has written to Prime … Continue reading

Posted in FTA, IP Rights, IPR, Trade Agreements, US-India FTA | Leave a comment

Doctors Without Borders Urges Modi Govt to Not Commit on Intellectual Property Rights to US

Source: News 18 21st September 2019   The international humanitarian medical body said any such trade package would affect millions of people who rely on affordable generic medicines produced in India.   New Delhi: Ahead of Prime Minister Narendra Modi’s visit to … Continue reading

Posted in IP Rights, Trade Agreements, US-India FTA | Leave a comment

Human Rights Council (2019): Core Group circulates zero draft on access to medicines and vaccines

Source: KEI 26th June, 2019   At the 41st session (24 June 2019 – 12 July 2019) of the Human Rights Council, a bloc of countries known as the the Core Group (Brazil, Egypt, Indonesia, India, Senegal, South Africa and Thailand) … Continue reading

Posted in Access to Medecines, IP Rights, Transparency | Leave a comment

At $2.1 million, newly approved Novartis gene therapy will be world’s most expensive drug

Source: Statnews 27th May, 2019   The Food and Drug Administration on Friday approved the first gene therapy for a type of spinal muscular atrophy, a lifesaving treatment for infants that will also be the most expensive drug in the world. … Continue reading

Posted in Gene Therapy, Novartis Case | Leave a comment

WHA72: Portuguese Minister of Health, Marta Temido, underscores strong support for the WHO transparency resolution

Source: Keionline 22nd May, 2019   On Monday, 20 May 2019, the Republic of Korea, Italy, Costa Rica, Greece, Indonesia, Italy, Mexico, Mongolia, Netherlands, Portugal, Republic of Korea, Saudi Arabia, Spain, and Vietnam convened an official side event at the 72nd … Continue reading

Posted in Access to Medecines, IP Rights, Transparency | Leave a comment